CLOUDR GROUP LTD. - Asset Resilience Ratio
CLOUDR GROUP LTD. (H3L) has an Asset Resilience Ratio of 3.25% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read CLOUDR GROUP LTD. balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how CLOUDR GROUP LTD.'s Asset Resilience Ratio has changed over time. See H3L total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down CLOUDR GROUP LTD.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see H3L company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €69.96 Million | 3.25% |
| Total Liquid Assets | €69.96 Million | 3.25% |
Asset Resilience Insights
- Limited Liquidity: CLOUDR GROUP LTD. maintains only 3.25% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
CLOUDR GROUP LTD. Industry Peers by Asset Resilience Ratio
Compare CLOUDR GROUP LTD.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
China National Medicines Corp Ltd
SHG:600511 |
Medical Distribution | 0.04% |
|
Liaoning Cheng Da Co Ltd
SHG:600739 |
Medical Distribution | 3.47% |
|
Paragon Care Limited
F:PXS |
Medical Distribution | 0.01% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Cyclopharm Ltd
AU:CYC |
Medical Distribution | 1.98% |
Annual Asset Resilience Ratio for CLOUDR GROUP LTD. (2021–2024)
The table below shows the annual Asset Resilience Ratio data for CLOUDR GROUP LTD..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 7.99% | €227.35 Million ≈ $265.80 Million |
€2.84 Billion ≈ $3.33 Billion |
-3.95pp |
| 2023-12-31 | 11.94% | €351.72 Million ≈ $411.20 Million |
€2.95 Billion ≈ $3.44 Billion |
-4.76pp |
| 2022-12-31 | 16.71% | €473.50 Million ≈ $553.57 Million |
€2.83 Billion ≈ $3.31 Billion |
+15.59pp |
| 2021-12-31 | 1.12% | €28.00 Million ≈ $32.73 Million |
€2.51 Billion ≈ $2.93 Billion |
-- |
About CLOUDR GROUP LTD.
ClouDr Group Limited provides supplies and software as a service (SaaS) installation to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management. The company's integrated in-hospital solution offers an AI-driven extensive hospital SaaS to assist doctors in diagnosis and treatment, and… Read more